• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Assessing preparedness for Alzheimer disease-modifying therapies in Australasian health care systems.

作者信息

Brodtmann Amy, Darby David, Oboudiyat Carly, Mahoney Colin J, Le Heron Campbell, Panegyres Peter K, Brew Bruce

机构信息

Monash University, Melbourne, VIC.

Florey Institute of Neuroscience and Mental Health, Melbourne, VIC.

出版信息

Med J Aust. 2023 Apr 3;218(6):247-249. doi: 10.5694/mja2.51880. Epub 2023 Mar 19.

DOI:10.5694/mja2.51880
PMID:36934371
Abstract
摘要

相似文献

1
Assessing preparedness for Alzheimer disease-modifying therapies in Australasian health care systems.评估澳大利亚医疗保健系统对阿尔茨海默病改善疗法的准备情况。
Med J Aust. 2023 Apr 3;218(6):247-249. doi: 10.5694/mja2.51880. Epub 2023 Mar 19.
2
The role of biomarkers in clinical trials for Alzheimer disease.生物标志物在阿尔茨海默病临床试验中的作用。
Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):6-15. doi: 10.1097/01.wad.0000191420.61260.a8.
3
Modifying the progression of Alzheimer's and Parkinson's disease with deep brain stimulation.利用深部脑刺激改变阿尔茨海默病和帕金森病的进展。
Neuropharmacology. 2020 Jul;171:107860. doi: 10.1016/j.neuropharm.2019.107860. Epub 2019 Nov 23.
4
Neuropsychiatric Aspects of Alzheimer Dementia: From Mechanism to Treatment.阿尔茨海默病的神经精神方面：从机制到治疗。
Psychiatr Clin North Am. 2020 Jun;43(2):383-397. doi: 10.1016/j.psc.2020.02.012. Epub 2020 Apr 22.
5
Some strategies for tackling the problems of senile dementia and related disorders within the next decade.未来十年内应对老年痴呆症及相关疾病问题的一些策略。
Dan Med Bull. 1985 Feb;32 Suppl 1:92-111.
6
Magnetic resonance in the differential diagnosis of dementia.磁共振成像在痴呆鉴别诊断中的应用
J Neural Transm (Vienna). 2002 Jul;109(7-8):1045-51. doi: 10.1007/s007020200088.
7
Expected wait times for access to a disease-modifying Alzheimer's treatment in the United States.美国获得阿尔茨海默病修饰治疗的预期等待时间。
Alzheimers Dement. 2022 May;18(5):1071-1074. doi: 10.1002/alz.12470. Epub 2021 Sep 27.
8
Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia.经颅聚焦超声打开血脑屏障治疗帕金森病痴呆。
Nat Commun. 2021 Feb 3;12(1):779. doi: 10.1038/s41467-021-21022-9.
9
Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease.早期诊断的准确性及其对阿尔茨海默病管理和病程的影响。
Expert Rev Mol Diagn. 2004 Jan;4(1):63-9. doi: 10.1586/14737159.4.1.63.
10
All patients with suspected dementia should be scanned at least once with CT or MRI.
Int Psychogeriatr. 2007 Jun;19(3):533-4; discussion 534-8. doi: 10.1017/S104161020623477X. Epub 2006 Dec 19.

引用本文的文献

1
Therapeutic time window of disease-modifying therapy for early Alzheimer's disease.早期阿尔茨海默病改善病情治疗的治疗时间窗
Alzheimers Dement (N Y). 2025 May 29;11(2):e70102. doi: 10.1002/trc2.70102. eCollection 2025 Apr-Jun.
2
The Holy Grail: highlighting the need for equitable access to dementia treatments and clinical trials.圣杯：凸显公平获得痴呆症治疗和临床试验的必要性。
Lancet Reg Health West Pac. 2025 Feb 8;55:101492. doi: 10.1016/j.lanwpc.2025.101492. eCollection 2025 Feb.
3
Risk factors for the neurodegenerative dementias in the Western Pacific region.
西太平洋地区神经退行性痴呆的风险因素。
Lancet Reg Health West Pac. 2024 Sep 16;50:101051. doi: 10.1016/j.lanwpc.2024.101051. eCollection 2024 Sep.
4
Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer's Disease in Japan.公众对日本阿尔茨海默病抗淀粉样蛋白治疗的医疗保健准备情况的看法。
Alzheimers Res Ther. 2024 Oct 3;16(1):205. doi: 10.1186/s13195-024-01568-8.
5
Regional Variability in MRI Scans with Different Magnetic Field Strengths in Japan: Implications for Healthcare Preparedness for Alzheimer's Disease Treatment.日本不同磁场强度MRI扫描的区域变异性：对阿尔茨海默病治疗医疗准备的影响
Biomedicines. 2024 Aug 16;12(8):1870. doi: 10.3390/biomedicines12081870.
6
Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.早期淀粉样蛋白PET重现帕金森病认知衰退的代谢特征。
Alzheimers Dement (Amst). 2024 Jun 22;16(2):e12601. doi: 10.1002/dad2.12601. eCollection 2024 Apr-Jun.